LI
CDMO

Leap Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Leap Investments’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40,217
Closed -$308K – 594
2019
Q4 		$308K Buy
40,217
+27,517
+217% +$161K 0.14% 240
2019
Q3 		$67K Buy
+12,700
New +$78.8K 0.03% 383

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Leap Investments's CDMO Position: Q1 2020 in Review

Leap Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2020, closing a stake of 40,217 shares — an estimated $308K sold.

Leap Investments first reported a position in CDMO in Q3 2019 and held it in 2 quarters. The position peaked at $308K in Q4 2019. 98 funds tracked by Wall St. Rank hold CDMO as of Q1 2020.

  • Leap Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Leap Investments sold 40,217 Avid Bioservices, Inc. Common Stock shares in Q1 2020, an estimated $308K.
  • Leap Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Leap Investments's Avid Bioservices, Inc. Common Stock position peaked at $308K in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.